Searched for
PHARMACEUTICAL GIANT
Aurobindo Pharma clears key US hurdle in Lannett acquisition, closing expected soonIndian drug giant Aurobindo Pharma is set for a major US expansion. The company has received crucial antitrust clearance from the US Federa...- Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...
- 'Not a great environment for Indian market': Harsha Upadhyaya on Iran-US tensions, IT outlook, pharma bet, and where to be cautiousGlobal challenges are impacting Indian stocks. West Asian tensions and rising US inflation create headwinds. Tech sector shifts also affect...
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- Alibaba, BYD, Baidu are helping China military - Pentagon makes shocking claimsUS-China relations: Pentagon's update on Monday comes months after it briefly released -- then withdrew -- an earlier version of the list w...
- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- Quant Mutual Fund bets on under-owned, under-researched, undervalued and neglected territory stocks for alpha generationQuant Mutual Fund is strategically focusing on under-owned, under-researched, and neglected market segments for higher alpha generation. Th...
- Texas emerges as US' new economic powerhouse amid California exodusHouston, Texas is leading corporate headquarters relocations, attracting 192 companies since 2018. Businesses are leaving California due to...
- Importance of India is now: US envoy Sergio Gor highlights Pharma trust, Pax Silica partnershipUS Ambassador to India Sergio Gor on Friday placed pharmaceuticals and the Pax Silica technology partnership at the centre of the growing I...
- Gene therapy for cholesterol: Initial test results cheerA new gene editing medicine, VERVE-102, offers hope for millions with heart conditions. Eli Lilly's drug showed significant reductions in b...
- 'India more diversified:' Sebi chief Tuhin Kanta Pandey comments on Taiwan's market ascentSEBI chief Tuhin Kanta Pandey emphasized India remains a diversified market despite Taiwan overtaking its market value. Driven by TSMC and ...
- Dividends, bonus issues: TCS, LIC, Bajaj Auto among 30 stocks turning ex-date this week. Check detailsInvestors must hold shares of these companies in their demat accounts on the record date to be eligible for the respective corporate action...
- Fortis liability case: Delhi HC says blame can't be shifted to third partyAmid ongoing legal disputes, the Delhi High Court is probing Fortis Healthcare's oversight concerning the sale of shares belonging to the S...
- Parle Melody: The ₹1 soft power twist Modi served to Meloni and the worldPrime Minister Modi's gift of a Parle Melody toffee to Italy's Giorgia Meloni symbolised India's evolving soft power. Beyond traditional ex...
- Want to jump into the 'China is back' rally? Tread carefullyInvestors are increasingly betting that “China is back” as the economy rebounds from years of deflation, helped by strong manufacturing, ex...
- Sensex surges over 800 points to cross 75,400; Nifty above 23,650 despite weak rupeeIn a recent turn of fortunes, Indian stock markets experienced a notable rise for the second consecutive day. On Thursday, both the Sensex ...
- The alchemist of Bengaluru: Kiran Mazumdar-Shaw began from a garageKiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who b...
- Tokyo Court to rule on Fortis arm IHH and Daiichi Sankyo disputeA significant legal battle between IHH Healthcare and Daiichi Sankyo is reaching its climax. The Tokyo District Court will announce its jud...
- IHH-Daiichi legal battle nears verdict on September 10A major legal battle between IHH Healthcare and Daiichi Sankyo is reaching its climax. IHH's subsidiary, NTK, is seeking JPY 200 billion in...
- Sun's strong gravity helps India Inc's pullSun Pharma has expanded its horizons by acquiring Organon, a notable New Jersey pharmaceutical firm. This strategic acquisition fortifies S...
Load More
